Delivery Order SPE2DB22D2206-SPE2DB24FKD18

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568700372 Posaconazole DR 100 mg Tablet 60s, a pharmaceutical product. The contract has a ceiling value of $3,073.39 and is a firm fixed price delivery order. The contract has an ultimate completion date of July 3, 2025. This contract is not set-aside and is open to...
This federal contract award, valued at $1,254.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 tablets of POSACONAZOLE DR 100 MG, a prescription medication, with a performance period extending until April 29, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,197.59, is for the supply of 4567331028 POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 21, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,676.82 Firm Fixed Price delivery order is for POSACONAZOLE DR 100 MG TABLET 60S, a medication, with a period of performance ending on June 12, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) designated as SPE2DX that Amerisourcebergen holds with DLA...
This federal contract award is for the delivery of 4,558,135,430 units of POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 17, 2022, with a ceiling value of $5,820.00. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 18, 2022. The contract is...
This federal contract award is for the delivery of 4,557,985 units of POSACONAZOLE DR 100 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $22,451.14 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of August 4, 2022 and was awarded on August 3, 2022. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,686.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the delivery of 4567717306 - POSACONAZOLE DR 100 MG TABLET 60S, with a period of performance running through March 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $5,365.46, is for the delivery of 4564491405 POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of May 6, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award is for the delivery of 4,562,841,818 units of POSACONAZOLE DR 100 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $29,449.54 and is a firm fixed price delivery order. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp...
The U.S. government awarded a $4,018.97 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract, awarded by the Department of Defense's Medical Supply Chain agency, is to provide 4,564,286,842 units of the pharmaceutical product POSACONAZOLE DR 100 MG TABLET 60S. The contract has an ultimate completion date of April 16, 2024 and was awarded on April 15, 2024 with no set-aside designation....
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKD18
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Posaconazole delayed-release 100 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $20,783.23 and an ultimate completion date of September 5, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which is valued at up to $999,999,999 through December 2025 for the delivery of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract is not set-aside and represents Amerisourcebergen's ongoing role as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including various defense and civilian agencies.

Generated 12/4/24, 10:09 AM